Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 35 EP applications Alexander W.G. Povey has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 18, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12740581

2 - (AZAINDOL- 2 -YL) BENZ IMIDAZOLES AS PAD4 INHIBITORS

IPC classification:
A61K 31/4184, A61K 31/407, C07D 471/04
Applicant:
Glaxo Group Limited
Agent:
Marks & Clerk
Agent:
Holger Tostmann, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Agent:
Alexander W.G. Povey, GlaxoSmithKline
Status:
PATENT GRANTED
EP14786355

COMPOUNDS FOR AFFINITY CHROMATOGRAPHY AND FOR EXTENDING THE HALF-LIFE OF A THERAPEUTIC AGENT

IPC classification:
A61K 47/22, A61K 31/4184, C07D 417/14, C07D 235/24, C07D 235/18, C07D 401/10, C07D 401/06
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
The patent has been granted
EP15730415

CHILD-PROOF PACKAGE

IPC classification:
B65D 75/32
Applicant:
Glaxo Group Limited
Agent:
Alexander W.G. Povey, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15836332

PACKAGE AND HEAT SEALING DEVICE

IPC classification:
B29C 65/00, B29C 65/02, B65D 53/06
Applicant:
GlaxoSmithKline LLC
Agent:
Alexander W.G. Povey, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15781902

DISPLAY PACK

IPC classification:
B65D 75/56, B65D 75/52, B65D 75/36
Agent:
Alexander W.G. Povey, GlaxoSmithKline
Status:
Request for examination was made
EP16716608

AN IMPROVED TOOTHBRUSH

IPC classification:
A46B 9/02, A61C 17/22, A61C 17/34
Agent:
Alexander W.G. Povey, GlaxoSmithKline
Status:
Request for examination was made
EP16756707

NOVEL DEVICE

IPC classification:
B65D 83/04, B65D 75/58
Agent:
Alexander W.G. Povey, GlaxoSmithKline
Status:
Request for examination was made
EP16804910

PHARMACEUTICAL COMPOSITIONS OF RIBAVIRIN

IPC classification:
A61K 31/7056, A61K 9/50, A61K 9/14
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Alexander W.G. Povey, GlaxoSmithKline
Status:
Request for examination was made
EP16819668

SUBSTITUTED BENZAZINONES AS ANTIBACTERIAL COMPOUNDS

IPC classification:
C07D 209/46, C07D 253/08, C07D 417/04, C07D 239/88, C07D 409/04, C07D 405/04, C07D 403/10, C07D 401/10, C07D 401/04, C07D 217/24
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Alexander W.G. Povey, GlaxoSmithKline
Status:
Request for examination was made
EP17701126

A SYSTEM AND METHOD FOR MOULDING A TUFTED BODY WITH A CURVED OUTER SURFACE

IPC classification:
B29C 45/14, A46D 3/00, A46B 9/04, A46B 9/02, A46B 3/06, A46B 3/04
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
Request for examination was made
EP17703049

A TEMPLATE FOR A TUFTED CURVED SURFACE

IPC classification:
A46D 3/04, A46B 9/04, A46B 9/02
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
Request for examination was made
EP17703392

AN ELECTRIC UTILITY BRUSH HAVING A FLEXIBLE DRIVE SHAFT

IPC classification:
A61C 17/26, A61C 1/18, A46B 13/02, A46B 5/00
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
Request for examination was made
EP17803322

INSULIN RECEPTOR PARTIAL AGONISTS AND GLP-1 ANALOGUES

IPC classification:
A61K 38/28
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17803382

INSULIN RECEPTOR PARTIAL AGONISTS

IPC classification:
C07K 19/00, C07K 14/62, A61K 38/28, A61K 38/00
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17803324

SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS USEFUL AS GPR120 AGONISTS

IPC classification:
C07D 217/02, A61P 3/10, A61K 31/4725, A61K 31/472
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17816016

CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07H 19/16, C07H 19/10, A61K 31/7056
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17816015

CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07H 19/16, C07H 19/10, A61K 31/7056
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17816018

USE OF CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07H 19/173, C07H 19/073, A61P 31/12, A61K 31/7068
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17841921

CHROMANE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND USES THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07D 519/00, C07D 493/00, C07D 498/10
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17841920

HETEROCYCLE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07D 513/04, A61K 45/06, C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17847239

NOVEL SUBSTITUTED N'-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS

IPC classification:
C07D 213/56, C07D 271/12, C07C 311/47
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17781253

CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61P 25/00, A61K 31/436, C07D 491/18, C07D 491/04
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17784507

BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS

IPC classification:
A61P 35/00, A61K 31/424, A61K 31/385, A61K 31/381, C07D 498/04, C07D 409/12, C07D 333/60
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17859538

KDM5 INHIBITORS

IPC classification:
C07D 471/04, A61K 31/4353
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17860647

KDM5 INHIBITORS

IPC classification:
C07D 471/04, A61K 31/4353
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17859662

N-ARYL AND N-HETEROARYL PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 239/42, C07F 9/02, C07D 239/02
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17860988

ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS

IPC classification:
C07D 401/02, C07D 211/14, C07D 211/08
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP19164594

AMIDE SUBSTITUTED INDAZOLES AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS

IPC classification:
A61P 29/00, A61P 35/00, A61K 31/4439, C07D 401/10
Applicant:
MSD Italia S.r.l.
Agent:
no data provided
Status:
The application has been published
EP17871593

INDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2

IPC classification:
C07D 237/26, C07D 231/56, C07D 231/00, A61K 31/416, A61K 31/415, A61K 31/381
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17871875

INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2

IPC classification:
C07D 209/08, C07D 209/04, C07D 209/02, A61K 31/405, A61K 31/404, A61K 31/403
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17879176

ANTIDIABETIC HETEROCYCLIC COMPOUNDS

IPC classification:
C07D 405/04, C07D 311/04, A61K 31/352, A61K 31/19
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17880145

HYDROXY ISOXAZOLE COMPOUNDS USEFUL AS GPR120 AGONISTS

IPC classification:
C07D 413/12, C07D 261/12
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17884984

CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT

IPC classification:
C07H 21/00, A61P 35/00, A61K 31/7084
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17884985

ANTIDIABETIC SPIROCHROMAN COMPOUNDS

IPC classification:
A61K 31/445, A61K 31/353, A61K 31/352
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made
EP17885367

COMBINATIONS OF PD-1 ANTAGONISTS AND CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT

IPC classification:
C07H 21/04, C07H 19/20, A61K 39/39
Applicant:
Merck & Co. Inc.
Agent:
no data provided
Status:
Request for examination was made

Please Sign in to use this feature